Carregant...
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors
Subacute cutaneous lupus erythematosus (SCLE) is an autoimmune disease that may be induced by proton pump inhibitors (PPIs) in at-risk populations. The US FDA does not recognize SCLE as an adverse event associated with PPIs. We queried the FDA Adverse Event Reporting System database, which contains...
Guardat en:
| Publicat a: | Drugs Real World Outcomes |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4914530/ https://ncbi.nlm.nih.gov/pubmed/27398293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-016-0067-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|